Literature DB >> 9125484

Immunodetection of glycoprotein hormone subunits in nonfunctioning and glycoprotein hormone-secreting pituitary adenomas.

K Saccomanno1, M Bassetti, A Lania, M Losa, G Faglia, A Spada.   

Abstract

While it is established that nonfunctioning pituitary adenomas (NFPA) produce a spectrum of glycoprotein hormones, the ability of glycoprotein hormone-secreting adenomas to synthesize hormones other than those in vivo hypersecreted has been poorly investigated so far. In this study the immunolocalization of the beta-subunits of LH, FSH, CG and TSH and the common alpha-subunit was investigated in 10 NFPA, 3 gonadotropin-secreting adenomas (Gn-omas, 1 LH-oma, 1 FSH-oma and 1 LH/FSH-oma) and 3 TSH-secreting adenomas (TSH-omas) using an immunohistochemical technique with specific antibodies to glycoprotein subunits. The percentage of positive cells was determined observing at least 5 photograph fields containing about 50 cells. Nine of the 10 NFPA were positive for FSH beta with a high percent of positive cells (> or =30%), 6 for LH beta and 5 for TSH beta with a lower number of labelled cells (from 5 to 30%). Of the 8 NFPA tested, 5 showed a marked positivity for CG beta. In Gn-omas, tumors were positive for the gonadotropin that was in vivo hypersecreted (10-60% positive cells) and negative for either TSH beta or CG beta. Similarly, in TSH-omas TSH beta was detected in a variable proportion of cells (10-30%) with no immunoreactivity for either LH beta or FSH beta or CG beta. This study indicates that the coexpression of FSH beta, LH beta, CG beta and TSH beta molecules is characteristic of NFPA since Gn-omas were negative for CG beta and TSH beta and TSH-omas were negative for FSH beta, LH beta and CG beta. Moreover, the biological events that make NFPA 'silent' glycoprotein hormone-secreting adenomas remain unclear since the positivity for gonadotropins and TSH showed by NFPA was similar to that observed in Gn-omas and TSH-omas, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125484     DOI: 10.1007/BF03347977

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas.

Authors:  S L Asa; B M Gerrie; W Singer; E Horvath; K Kovacs; H S Smyth
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

2.  Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.

Authors:  M Bassetti; A Spada; M Arosio; L Vallar; M Brina; G Giannattasio
Journal:  J Clin Endocrinol Metab       Date:  1986-06       Impact factor: 5.958

3.  Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.

Authors:  D J Kwekkeboom; F H de Jong; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

4.  In vitro detection of glycoprotein production and secretion by human nonfunctioning pituitary adenomas.

Authors:  K Saccomanno; P Gil del Alamo; M Bassetti; F Reza-Elahi; A Spada
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

5.  Serum levels of beta-subunit of chorionic gonadotropin in patients with pituitary tumors.

Authors:  P Gil-del-Alamo; K Saccomanno; A Lania; K S Pettersson; P Beck-Peccoz; A Spada
Journal:  Eur J Endocrinol       Date:  1995-07       Impact factor: 6.664

Review 6.  Gonadotroph cell adenomas of the pituitary.

Authors:  P J Snyder
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

7.  Glycoprotein hormone alpha-subunit in pituitary adenomas.

Authors:  P Beck-Peccoz; L Persani; G Faglia
Journal:  Trends Endocrinol Metab       Date:  1992-03       Impact factor: 12.015

8.  Recognition of gonadotroph adenomas in women.

Authors:  L Daneshdoost; T A Gennarelli; H M Bashey; P J Savino; R C Sergott; T M Bosley; P J Snyder
Journal:  N Engl J Med       Date:  1991-02-28       Impact factor: 91.245

9.  Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters.

Authors:  P Kopp; E T Kimura; S Aeschimann; M Oestreicher; A Tobler; M F Fey; H Studer
Journal:  J Clin Endocrinol Metab       Date:  1994-07       Impact factor: 5.958

10.  Clinically nonfunctioning pituitary tumors are monoclonal in origin.

Authors:  J M Alexander; B M Biller; H Bikkal; N T Zervas; A Arnold; A Klibanski
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

View more
  3 in total

1.  Serum FSH bioactivity and inhibin levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas.

Authors:  S Borgato; L Persani; R Romoli; D Cortelazzi; A Spada; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

2.  Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.

Authors:  M C Vantyghem; C Cortet; C Bauters; M H Gevaert; D Dewailly; J Lefebvre; M Mazzucca
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

3.  Beta human chorionic gonadotropin (beta-hCG) expression in pituitary adenomas: relationship to endocrine function and tumour recurrence.

Authors:  Paul M Doyle; Waziq A Thiryayi; Abhijit Joshi; Daniel du Plessis; Tara Kearney; Kanna K Gnanalingham
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.